Risk factors for asthma: is prevention possible? (Q38588853)

4 September 2017

Risk factors for asthma: is prevention possible? (English)

1 reference

4 September 2017

0 references

1

1 reference

4 September 2017

Alex Semprini

2

0 references

author name string

Edwin A Mitchell

series ordinal

3

1 reference

PubMed ID

26382999

4 September 2017

language of work or name

English

0 references

publication date

1 September 2015

1 reference

4 September 2017

1 reference

4 September 2017

386

1 reference

4 September 2017

1075-1085

1 reference

4 September 2017

9998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

4 September 2017

1 reference

7 January 2021

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Asthma phenotypes: the evolution from clinical to molecular approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Is current treatment increasing asthma mortality and morbidity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

New insights into the natural history of asthma: primary prevention on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Are there reasons why adult asthma is more common in females?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

1 reference

7 January 2021

Asthma genetics: from linear to multifactorial approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Regular smoking and asthma incidence in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Caesarean delivery and risk of atopy and allergic disease: meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prenatal and postnatal maternal stress and wheeze in urban children: effect of maternal sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

WHO European review of social determinants of health and the health divide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effect of breastfeeding on asthma, lung function and bronchial hyperreactivity in ISAAC Phase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Siblings, day-care attendance, and the risk of asthma and wheezing during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Respiratory infections precede adult-onset asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prenatal folic acid and risk of asthma in children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The acetaminophen and asthma hypothesis 10 years on: A case to answer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effect of urbanisation on asthma, allergy and airways inflammation in a developing country setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Risk factors for pediatric asthma. Contributions of poverty, race, and urban residence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Atopic sensitization and the international variation of asthma symptom prevalence in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

How much asthma is really attributable to atopy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Comorbidities of asthma during childhood: possibly important, yet poorly studied

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Asthma-related comorbidities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Exposure to farming environments in childhood and asthma and wheeze in rural populations: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Exposure to cats and dogs, and symptoms of asthma, rhinoconjunctivitis, and eczema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Association between domestic mould and mould components, and asthma and allergy in children: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Hunt for the origin of allergy - comparing the Finnish and Russian Karelia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Cooking fuels and prevalence of asthma: a global analysis of phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease: a global relationship in ISAAC phase 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Air pollution exposure and lung function in children: the ESCAPE project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Associations between environmental exposures and asthma control and exacerbations in young children: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Long-term inhaled corticosteroids in preschool children at high risk for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Respiratory syncytial virus and recurrent wheeze in healthy preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The immunostimulant OM-85 BV prevents wheezing attacks in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effects of maternal diet during late pregnancy and lactation on the development of atopic diseases in infants up to 18 months of age--in-vivo results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prebiotics in infants for prevention of allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Outcomes of the childhood asthma prevention study at 11.5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prevention of allergic sensitization by environmental control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Is there any role for allergen avoidance in the primary prevention of childhood asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Manchester Asthma and Allergy Study: Low-allergen environment can be achieved and maintained during pregnancy and in early life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Prospective study of acetaminophen use and newly diagnosed asthma among women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

1 reference

7 January 2021

Prospects for an asthma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

The platform trial: an efficient strategy for evaluating multiple treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Asthma: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

Epidemiology of childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900156-7

7 January 2021

10.1016/S0140-6736(15)00156-7

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26382999